RERE
Basic information
Region (hg38): 1:8352397-8848921
Previous symbols: [ "ATN1L" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (Strong), mode of inheritance: AD
- neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (Supportive), mode of inheritance: AD
- neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (Strong), mode of inheritance: AD
- complex neurodevelopmental disorder with or without congenital anomalies (Definitive), mode of inheritance: AD
- neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart | AD | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Genitourinary; Neurologic; Ophthalmologic | 27087320 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (641 variants)
- Inborn_genetic_diseases (259 variants)
- Neurodevelopmental_disorder_with_or_without_anomalies_of_the_brain,_eye,_or_heart (173 variants)
- RERE-related_disorder (67 variants)
- not_specified (30 variants)
- See_cases (7 variants)
- CHARGE_syndrome (1 variants)
- Neurodevelopmental_disorder (1 variants)
- Cerebral_visual_impairment_and_intellectual_disability (1 variants)
- Autism_spectrum_disorder (1 variants)
- Intellectual_disability (1 variants)
- Cleft_palate (1 variants)
- Developmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RERE gene is commonly pathogenic or not. These statistics are base on transcript: NM_001042681.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 147 | 27 | 180 | |||
missense | 17 | 476 | 111 | 11 | 621 | |
nonsense | 12 | |||||
start loss | 0 | |||||
frameshift | 10 | 15 | 29 | |||
splice donor/acceptor (+/-2bp) | 10 | |||||
Total | 20 | 45 | 491 | 258 | 38 |
Highest pathogenic variant AF is 0.0000087548
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RERE | protein_coding | protein_coding | ENST00000337907 | 22 | 465246 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 7.65e-9 | 125713 | 0 | 34 | 125747 | 0.000135 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.03 | 737 | 909 | 0.810 | 0.0000589 | 10049 |
Missense in Polyphen | 187 | 316.28 | 0.59124 | 3317 | ||
Synonymous | -2.83 | 453 | 383 | 1.18 | 0.0000269 | 3205 |
Loss of Function | 7.11 | 3 | 64.7 | 0.0463 | 0.00000377 | 718 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000254 | 0.000182 |
Ashkenazi Jewish | 0.000211 | 0.000198 |
East Asian | 0.000111 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000379 | 0.000211 |
Middle Eastern | 0.000111 | 0.0000544 |
South Asian | 0.000247 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role as a transcriptional repressor during development. May play a role in the control of cell survival. Overexpression of RERE recruits BAX to the nucleus particularly to POD and triggers caspase-3 activation, leading to cell death. {ECO:0000269|PubMed:11331249}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving RERE is found in the neuroblastoma cell line NGP. Translocation t(1;15)(p36.2;q24).; DISEASE: Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart (NEDBEH) [MIM:616975]: An autosomal dominant syndrome characterized by developmental delay, intellectual disability, brain anomalies, and neurological abnormalities including seizures, hypotonia, and behavioral problems such as autism spectrum disorders. Brain anomalies include abnormalities and/or thinning of the corpus callosum, diminished white matter volume, abnormal cerebellar vermis, and ventriculomegaly. Congenital defects of the eye, heart and genitourinary system are present in half of the patients. {ECO:0000269|PubMed:27087320}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- loftool
- 0.0674
- rvis_EVS
- -2.63
- rvis_percentile_EVS
- 0.78
Haploinsufficiency Scores
- pHI
- 0.870
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.621
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.717
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rere
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; renal/urinary system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype;
Zebrafish Information Network
- Gene name
- rerea
- Affected structure
- hair cell
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- chromatin remodeling;regulation of transcription by RNA polymerase II;NLS-bearing protein import into nucleus;cerebellar Purkinje cell layer maturation;cerebellar granule cell precursor proliferation;radial glia guided migration of Purkinje cell;branching morphogenesis of a nerve;dendrite morphogenesis;negative regulation of nucleic acid-templated transcription;positive regulation of nucleic acid-templated transcription
- Cellular component
- histone deacetylase complex;nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;DNA binding;chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;poly-glutamine tract binding;zinc ion binding;sequence-specific DNA binding